• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在FTY720治疗下,肾移植中出现抗体介导的排斥反应,并伴有显著的间质单核细胞/巨噬细胞浸润。

Antibody-mediated rejection with a striking interstitial monocyte/macrophage infiltration in a renal allograft under FTY720 treatment.

作者信息

Sis Banu, Grynoch Richard, Murray Allan G, Campbell Patricia, Solez Kim

机构信息

Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.

出版信息

Am J Kidney Dis. 2008 Jan;51(1):127-30. doi: 10.1053/j.ajkd.2007.08.023.

DOI:10.1053/j.ajkd.2007.08.023
PMID:18155542
Abstract

FTY720, a novel immunomodulator, causes rapid temporary depletion of peripheral-blood lymphocytes, inducing their sequestration in secondary lymphoid organs. FTY720 is effective in animal models of transplantation and is under evaluation for use in human transplantation. We report a 48-year-old renal transplant recipient who developed acute antibody-mediated rejection under a high-dose FTY720 (5 mg/d), low-dose cyclosporine A, and prednisone treatment protocol. A T-cell antihuman globulin and National Institutes of Health extended B-cell cross-match with donor cells were negative before transplantation. At 10 weeks posttransplantation, serum creatinine level increased and a renal biopsy showed a striking interstitial CD68(+) monocyte/macrophage infiltration with C4d staining of peritubular capillaries. Flow panel reactive antibody levels were positive in the recipient's serum for class I (9%) and class II (75%). The positive panel reactive antibody levels and presence of C4d in peritubular capillaries justified the diagnosis of antibody-mediated rejection. However, the presence of macrophage-rich interstitial infiltrate suggested a contribution of cellular rejection. The morphological characteristic of rejection with a striking interstitial CD68(+) monocyte/macrophage infiltration with paucity of T cells is very unusual and may reflect a unique effect of FTY720 therapy.

摘要

新型免疫调节剂FTY720可导致外周血淋巴细胞迅速短暂耗竭,促使其在二级淋巴器官中滞留。FTY720在移植动物模型中有效,目前正在评估其在人类移植中的应用。我们报告了一名48岁的肾移植受者,该患者在高剂量FTY720(5毫克/天)、低剂量环孢素A和泼尼松治疗方案下发生了急性抗体介导的排斥反应。移植前,T细胞抗人球蛋白和美国国立卫生研究院扩展的与供体细胞的B细胞交叉配型均为阴性。移植后10周,血清肌酐水平升高,肾活检显示间质有明显的CD68(+)单核细胞/巨噬细胞浸润,肾小管周围毛细血管C4d染色阳性。受者血清中I类(9%)和II类(75%)的流式细胞仪群体反应性抗体水平呈阳性。群体反应性抗体水平阳性以及肾小管周围毛细血管中存在C4d证实了抗体介导的排斥反应的诊断。然而,富含巨噬细胞的间质浸润提示存在细胞性排斥反应。排斥反应的形态学特征为间质有明显的CD68(+)单核细胞/巨噬细胞浸润且T细胞稀少,这种情况非常罕见,可能反映了FTY720治疗的独特作用。

相似文献

1
Antibody-mediated rejection with a striking interstitial monocyte/macrophage infiltration in a renal allograft under FTY720 treatment.在FTY720治疗下,肾移植中出现抗体介导的排斥反应,并伴有显著的间质单核细胞/巨噬细胞浸润。
Am J Kidney Dis. 2008 Jan;51(1):127-30. doi: 10.1053/j.ajkd.2007.08.023.
2
Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine.使用依维莫司或FTY720联合环孢素治疗晚期慢性移植肾肾病。
Transplant Proc. 2008 Dec;40(10):3731-6. doi: 10.1016/j.transproceed.2008.06.114.
3
Depletion of cells of monocyte lineage prevents loss of renal microvasculature in murine kidney transplantation.单核细胞谱系细胞的耗竭可防止小鼠肾移植中肾微血管的丧失。
Transplantation. 2008 Nov 15;86(9):1267-74. doi: 10.1097/TP.0b013e318188d433.
4
FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A.FTY720是一种改变淋巴细胞迁移的免疫抑制剂,与环孢素A联合使用可消除慢性排斥反应。
Transplantation. 2003 Apr 15;75(7):945-52. doi: 10.1097/01.TP.0000058469.38572.10.
5
Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.1-磷酸鞘氨醇受体激动作用会损害皮肤树突状细胞迁移以及归巢至二级淋巴组织的能力:与移植器官长期存活相关。
Transpl Immunol. 2008 Nov;20(1-2):88-94. doi: 10.1016/j.trim.2008.07.004. Epub 2008 Aug 9.
6
FTY720 reduces extracellular matrix expansion associated with ischemia-reperfusion induced injury.FTY720可减少与缺血再灌注诱导损伤相关的细胞外基质扩张。
Transplant Proc. 2007 Dec;39(10):2992-6. doi: 10.1016/j.transproceed.2007.04.027.
7
Blood group Lewis alloantibodies cause antibody-mediated rejection in renal transplant recipients.血型Lewis同种抗体可导致肾移植受者发生抗体介导的排斥反应。
Transplant Proc. 2007 Nov;39(9):2711-4. doi: 10.1016/j.transproceed.2007.08.053.
8
Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation.大鼠小肠移植中供体或受体术前使用FTY720后的排斥反应。
Transpl Immunol. 2004 Nov;13(3):161-8. doi: 10.1016/j.trim.2004.06.004.
9
Subclinical peritubular capillaritis in serial graft biopsies in cadaveric kidney transplant recipient with pre-transplant anti-HLA antibodies.在有移植前抗HLA抗体的尸体肾移植受者的系列移植肾活检中发现的亚临床肾小管周围毛细血管炎。
Clin Transplant. 2009 Aug;23 Suppl 20:34-8. doi: 10.1111/j.1399-0012.2009.01007.x.
10
FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation.新型免疫调节剂FTY720:初治肾移植患者2A期首项研究的疗效与安全性结果
Transplantation. 2004 Jun 27;77(12):1826-33.

引用本文的文献

1
Mouse Model Established by Early Renal Transplantation After Skin Allograft Sensitization Mimics Clinical Antibody-Mediated Rejection.皮肤同种异体移植致敏后早期肾移植建立的小鼠模型模拟临床抗体介导的排斥反应。
Front Immunol. 2018 Jul 4;9:1356. doi: 10.3389/fimmu.2018.01356. eCollection 2018.
2
Renal allograft granulomatous interstitial nephritis: observations of an uncommon injury pattern in 22 transplant recipients.肾移植受者的移植肾肉芽肿性间质性肾炎:22例移植受者罕见损伤模式的观察
Clin Kidney J. 2017 Apr;10(2):240-248. doi: 10.1093/ckj/sfw117. Epub 2017 Feb 1.
3
Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury.
移植中的抗体:HLA和非HLA抗体结合的影响及损伤机制
Methods Mol Biol. 2013;1034:41-70. doi: 10.1007/978-1-62703-493-7_2.
4
HLA class I antibodies trigger increased adherence of monocytes to endothelial cells by eliciting an increase in endothelial P-selectin and, depending on subclass, by engaging FcγRs.HLA Ⅰ类抗体通过诱导内皮细胞 P 选择素增加,并根据亚类通过结合 FcγR,触发单核细胞与内皮细胞的黏附增加。
J Immunol. 2013 Jun 15;190(12):6635-50. doi: 10.4049/jimmunol.1201434. Epub 2013 May 20.
5
Blockade of p-selectin is sufficient to reduce MHC I antibody-elicited monocyte recruitment in vitro and in vivo.阻断 P-选择素足以减少 MHC I 抗体引发的体外和体内单核细胞募集。
Am J Transplant. 2013 Feb;13(2):299-311. doi: 10.1111/ajt.12016. Epub 2012 Dec 27.
6
Modulation of chemokines and allergic airway inflammation by selective local sphingosine-1-phosphate receptor 1 agonism in lungs.肺部选择性局部鞘氨醇-1-磷酸受体 1 激动剂对趋化因子和过敏性气道炎症的调节作用。
Mol Pharmacol. 2011 Jan;79(1):61-8. doi: 10.1124/mol.110.066811. Epub 2010 Oct 8.